Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 834 results for "mylan"

Mylan N.V. and Mylan Inc. Announce Successful Completion of Consent Solicitations for Mylan Inc.'s Notes
RCL Advisors

Mylan launches new dosage strengths of pain therapy

Mylan N.V. and Mylan Inc., a generic pharmaceutical company, have launched Fentanyl Transdermal System 37.5, 62.5 and 87.5mcg/hr, indicated for the treatment of chronic pain, in the US. These three strengths are new additions to its existing ..., 1 week ago

134 images for mylan

Seeking Alpha, 2 days ago
Seeking Alpha, 2 days ago
Seeking Alpha, 2 days ago
Seeking Alpha, 2 days ago
Seeking Alpha, 2 days ago
Good Day Sacramento, 2 weeks ago
Monthly Prescribing Reference, 2 weeks ago
Yahoo! Finance, 2 weeks ago, 2 weeks ago, 2 weeks ago
The Telegraph

US drugmaker Mylan to acquire Famy Care for $750 Million

ureau | 3 Feb, 2015, 05.26AM IST Post a Comment MUMBAI: Mylan, the world's second biggest generic drugs maker, will pay $750 million or about Rs 4,944 crore to buy the women's health business of Mumbai-based Famy Care and expand its presence in the market for ...
 Economic Times1 month ago Mylan in buy mode  The Telegraph1 month ago Mylan buys Famy Care's contraceptive biz for $800m  Times of India1 month ago Mylan Inc to acquire Famy Care's certain biz for USD 800 mn  Business Standard1 month ago
Med India

Mylan Soon to Distribute Hepatitis C Drugs in India

Mylan, US drug maker soon to distribute two drugs in India to treat liver diseases. Mylan Pharmaceuticals said its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has received exclusive rights to distribute the branded medicines Sovaldi for liver ...
 Med India1 month ago Mylan to distribute Gilead's Hepatitis C drugs in India  Business Standard1 month ago Dr. Reddy's, Hetero Drugs sign agreement to sell Hepatitis C drug  Livemint.com5 days ago Drugs of 7 Indian pharma firms in EMA's suspension list  Rediff.com1 month ago
Business Standard

Natco Pharma's US partner Mylan files application with USFDA

Drug firm Natco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly for treatment of liver and kidney cancers. The company's marketing partner Mylan Inc has filed an ...
 Business Standard1 month ago Natco Pharma's partner Mylan files application for Sorafenib with the USFDA  Business Standard1 month ago Natco Pharma launches Hepatitis-C drug Sovaldi in Nepal  The Financial Chronicle2 weeks ago Gilead loses patent battle on expensive Hepatitis-C drug  Deccan Herald2 months ago
Business Standard

Mylan expands hepatitis-C agreement with Gilead

Drug could become the first all-oral single tablet regimen for all hepatitis-C genotypes BS Reporter | Hyderabad January 27, 2015 Last Updated at 20:41 IST US generics pharmaceuticals maker Mylan Inc today said that its subsidiary Mylan Laboratories Limited, ...
 Business Standard1 month ago
India Infoline

Mylan the winner in PHARMAC tenders

 Pharma In Focus1 week ago Cipla, Mylan in race to acquire select brands of Sun Pharma: Reports  India Infoline1 month ago Pharmexcil to set up campus at Pharma City  The Hindu1 week ago Pharmacy colleges demand NIPER in city  Times of India1 week ago

Health Canada Release: Advisory - Mylan Inc. (MYL) Recalls Methotrexate Injection (USP 50mg/2mL) Due to Particulate Matter 3/12/2015

/CNW/ - The issue: Mylan Pharmaceuticals ULC, in consultation with Health Canada, is voluntarily recalling one lot of Methotrexate Injection USP 50 mg/2 mL due to the potential presence of foreign particulate matter. At this time, no other lots ...
 ClinicSpace2 weeks ago Advisory - Mylan Recalls Methotrexate Injection (USP 50mg/2mL) Due To Particulate Matter  Market Pulse Navigator2 weeks ago Mylan Recalls Methotrexate Injection (USP 50mg/2mL) Due To Particulate Matter  Health Canada2 weeks ago Advisory Mylan Recalls Methotrexate Injection (USP 50mg/2mL) Due To Particulate Matter  Gnom.es2 weeks ago
Med India

Mylan Loses Court Fight Over Multiple Sclerosis Drug

The Supreme Court has ruled against generic drugmakerMylan Inc. and other firms in their challenge of Teva PharmaceuticalIndustries' patents for a blockbuster multiple sclerosis drug. The justices ruled 7-2 that a federal appeals courtwrongly overturned five ...
 Med India2 months ago

Mylan (MYL) Breaks Through Support at $62.67

Shares of Mylan (NASDAQ:MYL) have bearishly opened below the pivot of $63.36 today and have reached the first support level of $62.67. Investors may be interested in a cross of the next downside pivot targets of $62.24
 Individual.com3 days ago Mylan Laboratories (MYL) Trading Near $61.04 Support Level  Individual.com4 days ago Watch for Shares of Mylan (MYL) to Approach Resistance at $64.38  Individual.com1 week ago Mylan Laboratories (MYL) Showing Support Near $53.39  Individual.com2 weeks ago

Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Revision: 3, Authorised

This is a summary of the European public assessment report (EPAR) for Zoledronic acid Mylan. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing ...
 European Medicines Agency3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less